Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50020
Title: | Outcomes studied in leukaemia clinical trials : a need for harmonisation? |
Authors: | Said, Dylan Borg, John-Joseph Attard Pizzuto, Maresca Serracino-Inglott, Anthony |
Keywords: | Leukemia -- Treatment Leukemia -- Diagnosis Clinical trials -- Decision making Clinical trials -- Evaluation Technology assessment, Biomedical Communication in medicine -- Evaluation |
Issue Date: | 2019-09 |
Publisher: | University of Malta. Department of Pharmacy |
Citation: | Said, D., Borg, J. J., Attard Pizzuto, M., & Serracino-Inglott, A. (2019, September). Outcomes studied in leukaemia clinical trials: a need for harmonisation?. Poster session presented at the FIP World Congress of Pharmacy and Pharmaceutical Sciences, Abu Dhabi, United Arab Emirates. |
Abstract: | A poster presentation regarding outcomes studied in leukaemia clinical trials. Introduction: Heterogeneity in outcomes measured in clinical trials (CTs) and clinical studies for antineoplastic therapies presents as a major barrier to evidence synthesis, increasing the complexity of regulatory, policy and healthcare decision-making. Highlighting the magnitude of inconsistency, sources report that over 25,000 of outcomes in cancer trials have only been used once or twice. Aims: •To identify unique efficacy parameters investigated in leukaemia CTs; •To determine the degree of variability of efficacy outcomes studied in trials for the following four main leukaemia subtypes: Acute Lymphoblastic Leukaemia (ALL), Acute Myeloid Leukaemia (AML), Chronic Lymphocytic Leukaemia (CLL) and Chronic Myeloid Leukaemia (CML). |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/50020 |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Outcomes_studied_in_leukaemia_clinical_trials_a_need_for_harmonisation_2019.pdf | 1.68 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.